Atypical Femoral Fracture in a Patient with Rheumatoid Arthritis |
Kim, Dam
(Department of Rheumatology, Hospital for Rheumatic Diseases, Hanyang University College of Medicine)
Jung, Sodam (Department of Internal Medicine, Hanyang University College of Medicine) Son, Chang-Nam (Department of Rheumatology, Hospital for Rheumatic Diseases, Hanyang University College of Medicine) Choi, Ji-Young (Department of Rheumatology, Hospital for Rheumatic Diseases, Hanyang University College of Medicine) Lee, Seunghun (Department of Radiology, Hanyang University College of Medicine) Kim, Yee-Suk (Department of Orthoperdic Surgery, Hanyang University College of Medicine) Sung, Yoon-Kyoung (Department of Rheumatology, Hospital for Rheumatic Diseases, Hanyang University College of Medicine) |
1 | Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008;22:346-350. DOI ScienceOn |
2 | Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a longterm complication of alendronate therapy? Injury 2008;39:224-231. DOI ScienceOn |
3 | Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573-1579. DOI ScienceOn |
4 | Edwards BJ, Bunta AD, Lane J, et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am 2013;95:297-307. DOI ScienceOn |
5 | Lee YK, Ha YC, Park C, Yoo JJ, Shin CS, Koo KH. Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos Int 2013;24:707-711. DOI ScienceOn |
6 | Schilcher J, Michaelsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011;364:1728-1737. DOI ScienceOn |
7 | Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res 2013;28:1729-1737. DOI |
8 | Sung YB, Choi JY, Um KS. Bisphosphonate related atypical femoral fracture. Hip Pelvis 2013;25:66-71. DOI |
9 | Das De S, Setiobudi T, Shen L, Das De S. A rational approach to management of alendronate-related subtrochanteric fractures. J Bone Joint Surg Br 2010;92:679-686. |
10 | Girgis CM, Sher D, Seibel MJ. Atypical femoral fractures and bisphosphonate use. N Engl J Med 2010;362:1848-1849. DOI ScienceOn |